Sana Biotechnology Inc vs Wendys Co — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Wendys Co trades at $7.62 (market cap $1.50B). The key difference: Wendys Co is the larger of the two by market cap, and Wendys Co pays a 7.13% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | WEN | |
|---|---|---|
Market Cap | $873.84M | $1.50B |
Sector | Health | Consumer Cyclical |
52-Week High | $5.92 | $11.33 |
52-Week Low | $2.68 | $6.17 |
Enterprise Value | $848.03M | $5.31B |
Dividend Yield | — | 7.13% |
Trailing returns across standard periods
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $11.1 billion in 2021, narrowly edging Burger King ($10.3 billion) and clocking in well behind wide-moat McDonald's ($45.7 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spans almost 7,000 total units in 30 countries. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for 94% of stores, and through franchise flipping and advisory fees.
Read more on WEN →